ISRCTN12525141进行中（未招募）Unknown
Evaluation of the marginal bone level change of Straumann Bone Level Tapered® implants using different screwed abutment height in partially edentulous patients: a randomized controlled clinical trial
niversitat Internacional de Catalunya0 个研究点目标入组 98 人开始时间: 2023年5月26日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 98
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Signed informed consent
- •2. Overall, healthy subjects
- •3. Females and males of at least eighteen-years
- •4. Requiring a minimum of two implants (molar and/or premolar teeth)
- •5. Adequate oral hygiene (less than 15% FMPS)
- •6. Able to follow instructions and attend a regular compliance
- •7. Enough bone to place a standard implant of 4.1 mm diameter
排除标准
- •1. Acute local infection
- •2. Occlusal overload with parafunctional activity (assessed clinically)
- •3. Large occlusal discrepancies
- •4. Untreated periodontal disease assessed by Socransky et al. parameters (=2mm clinical attachment loss in two consecutive visits within 1 year)
- •5. Smokers (more than 10 cigarettes/day)
- •6. Drug and/or alcoholic dependencies
- •7. Medical conditions contraindicating implant surgery
- •8. History of head and/or neck radiation
- •9. Bisphosphonate therapy
研究者
相似试验
招募中
2 期
Evaluation of marginal bone level around short maxillary implantsIRCT2017021025662N2Vice chancellor for research, Tehran University of Medical Sciences16
招募中
不适用
Evaluation of two types of implants installed in the jawPatients with partially edentulous jaw that need to be restored with single crownsC05.500.480.450RBR-6c2k3mniversidade de São Paulo
已完成
3 期
Bone density changes before and after administration of danozoomabIRCT20210803052067N1Artesh University of Medical Sciences202
已完成
早期 1 期
Comparison of one vs two implant overdentutresbone loss.Other specified disorders of bone density and structureIRCT201010265029N1Dental School, Hamadan Medical Science University20
进行中（未招募）
1 期
Changes in bone density and bone turnover in patients with rheumatoid arthritis treated with rituximab, a B cell depleting monoclonal antibody.An investigator-led, industry supported, multicentre, open-label, single treatment arm, prospective clinical trial. - Effects of B cell depletion on bone turnover in rheumatoid arthritis.rheumatoid arthritisEUCTR2010-020499-50-GBSouth Tees Hospitals NHS Foundation Trust46